Search Results Search Sort by RelevanceMost Recent AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. AMA Code Says Dec 2018 AMA Code of Medical Ethics’ Opinions Related to a Physician’s Power to Name Scott J. Schweikart, JD, MBE The Code offers guidance about delivering a diagnosis and promoting patients’ best interests when assigning names to patients’ conditions. AMA J Ethics. 2018;20(12):E1139-1142. doi: 10.1001/amajethics.2018.1139. Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606. Art of Medicine Feb 2020 Risks, Benefits, and Conundrums of Cancer Screening Nick Love, PhD A patient’s story represents an ethical dilemma of cancer screening: it can save lives but generates diagnostic morbidity and incurs costs. AMA J Ethics. 2020;22(2):E164-165. doi: 10.1001/amajethics.2020.164. In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page Next › Last page Last »
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
AMA Code Says Dec 2018 AMA Code of Medical Ethics’ Opinions Related to a Physician’s Power to Name Scott J. Schweikart, JD, MBE The Code offers guidance about delivering a diagnosis and promoting patients’ best interests when assigning names to patients’ conditions. AMA J Ethics. 2018;20(12):E1139-1142. doi: 10.1001/amajethics.2018.1139.
Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606.
Art of Medicine Feb 2020 Risks, Benefits, and Conundrums of Cancer Screening Nick Love, PhD A patient’s story represents an ethical dilemma of cancer screening: it can save lives but generates diagnostic morbidity and incurs costs. AMA J Ethics. 2020;22(2):E164-165. doi: 10.1001/amajethics.2020.164.
In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.